Molecular ‘switch’ that turns on inflammation in obesity points to new therapeutic targets

Obesity increased SAMHD1 phosphorylation and thereby compromised its deoxynucleoside triphosphatase function, ultimately leading to aberrant accumulation of cytosolic dNTPs…

Continue Reading


News Source: medicalxpress.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *